The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-n-dodecyl-D-galactonoamidine ID: ALA3359675
PubChem CID: 137007060
Max Phase: Preclinical
Molecular Formula: C18H36N2O4
Molecular Weight: 344.50
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCCCCCCC/N=C1\N[C@H](CO)[C@H](O)[C@H](O)[C@H]1O
Standard InChI: InChI=1S/C18H36N2O4/c1-2-3-4-5-6-7-8-9-10-11-12-19-18-17(24)16(23)15(22)14(13-21)20-18/h14-17,21-24H,2-13H2,1H3,(H,19,20)/t14-,15+,16+,17-/m1/s1
Standard InChI Key: OZZTYUDTMQTEKD-LTIDMASMSA-N
Molfile:
RDKit 2D
24 24 0 0 0 0 0 0 0 0999 V2000
1.8573 -17.1197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8573 -17.9369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5625 -18.3414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2678 -17.9369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2678 -17.1197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5625 -16.7070 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9767 -16.7132 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9749 -18.3466 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5625 -19.1586 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.1501 -18.3466 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.1484 -16.7132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1460 -15.8960 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9791 -15.8960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6880 -15.4895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6921 -14.6785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9865 -14.2663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9906 -13.4491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2850 -13.0370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2891 -12.2198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5835 -11.8076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8737 -12.2126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8696 -13.0298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1598 -13.4348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1557 -14.2520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
5 7 2 0
4 8 1 6
3 9 1 1
2 10 1 1
1 11 1 1
11 12 1 0
7 13 1 0
13 14 1 0
15 14 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 344.50Molecular Weight (Monoisotopic): 344.2675AlogP: 1.35#Rotatable Bonds: 12Polar Surface Area: 105.31Molecular Species: NEUTRALHBA: 5HBD: 5#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.52CX Basic pKa: 7.97CX LogP: 1.75CX LogD: 1.09Aromatic Rings: ┄Heavy Atoms: 24QED Weighted: 0.34Np Likeness Score: 0.88
References 1. Fan QH, Claunch KA, Striegler S.. (2014) Structure-activity relationship of highly potent galactonoamidine inhibitors toward β-galactosidase (Aspergillus oryzae)., 57 (21): [PMID:25295392 ] [10.1021/jm501111y ] 2. Pickens JB, Striegler S, Fan QH.. (2016) Arabinoamidine synthesis and its inhibition toward β-glucosidase (sweet almonds) in comparison to a library of galactonoamidines., 24 (16): [PMID:27298003 ] [10.1016/j.bmc.2016.04.069 ]